Comparative Studies Of Noopept And Piracetam In The Treatment Of Patients With Mild Cognitive Disorders In Organic Brain Diseases Of Vascular And Traumatic Origin

Effect Increase
Trial Design Cohort
Trial Length 1-6 months
Number of Subjects 41
Gender Both Genders
Age Range 45-64, 65+
Notes for this study:
No placebo control, but Noopept at 10mg twice daily appeared to be more effective than the reference drug of Piracetam (1200mg daily) in aiding in recovery of brain damage from vascular damage, although Noopept was also effective against physical trauma.